E. Ohman J or Asset Management AB Grows Position in Colgate-Palmolive (NYSE:CL)

E. Ohman J or Asset Management AB boosted its position in shares of Colgate-Palmolive (NYSE:CL) by 1,108.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 386,730 shares of the company’s stock after buying an additional 354,730 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in Colgate-Palmolive were worth $35,158,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. D Orazio & Associates Inc. raised its holdings in shares of Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after acquiring an additional 108 shares in the last quarter. Fiducient Advisors LLC increased its position in Colgate-Palmolive by 5.2% during the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after purchasing an additional 110 shares during the period. Sequoia Financial Advisors LLC raised its holdings in Colgate-Palmolive by 0.6% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after purchasing an additional 113 shares in the last quarter. Waldron Private Wealth LLC lifted its position in shares of Colgate-Palmolive by 2.1% in the 3rd quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock worth $585,000 after purchasing an additional 118 shares during the period. Finally, Commonwealth Financial Services LLC boosted its stake in shares of Colgate-Palmolive by 4.5% during the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock valued at $247,000 after purchasing an additional 118 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.4 %

Shares of Colgate-Palmolive stock opened at $87.05 on Tuesday. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The company’s 50 day moving average is $91.35 and its 200 day moving average is $97.15. The company has a market cap of $71.12 billion, a price-to-earnings ratio of 24.73, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company posted $0.87 EPS. Research analysts anticipate that Colgate-Palmolive will post 3.74 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.30%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 56.82%.

Wall Street Analysts Forecast Growth

CL has been the subject of several research analyst reports. Morgan Stanley lowered their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a report on Monday. Royal Bank of Canada restated a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Raymond James reiterated an “outperform” rating and issued a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday. Barclays dropped their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. Finally, TD Cowen decreased their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and a consensus price target of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.